Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glycosylated Ferritin in Differential Diagnosis of Still's Disease, Sepsis and Other Macrophagic Activation Syndromes.

NCT02143986 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.

NCT NCT02143986
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02143986 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glycosylated Ferritin in Differential Diagnosis of Still's Disease, Sepsis and Other Macrophagic Activation Syndromes.
Lead sponsor
Brugmann University Hospital
Phase
Observational
Overall status
Recruiting
Start date
May 31, 2014
Completion date
December 31, 2030
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macrophagic activation syndrome, sepsis, still's disease, adult-onset